Literature DB >> 33847518

Pulmonary Functional Imaging: Part 2-State-of-the-Art Clinical Applications and Opportunities for Improved Patient Care.

Warren B Gefter1, Kyung Soo Lee1, Mark L Schiebler1, Grace Parraga1, Joon Beom Seo1, Yoshiharu Ohno1, Hiroto Hatabu1.   

Abstract

Pulmonary functional imaging may be defined as the regional quantification of lung function by using primarily CT, MRI, and nuclear medicine techniques. The distribution of pulmonary physiologic parameters, including ventilation, perfusion, gas exchange, and biomechanics, can be noninvasively mapped and measured throughout the lungs. This information is not accessible by using conventional pulmonary function tests, which measure total lung function without viewing the regional distribution. The latter is important because of the heterogeneous distribution of virtually all lung disorders. Moreover, techniques such as hyperpolarized xenon 129 and helium 3 MRI can probe lung physiologic structure and microstructure at the level of the alveolar-air and alveolar-red blood cell interface, which is well beyond the spatial resolution of other clinical methods. The opportunities, challenges, and current stage of clinical deployment of pulmonary functional imaging are reviewed, including applications to chronic obstructive pulmonary disease, asthma, interstitial lung disease, pulmonary embolism, and pulmonary hypertension. Among the challenges to the deployment of pulmonary functional imaging in routine clinical practice are the need for further validation, establishment of normal values, standardization of imaging acquisition and analysis, and evidence of patient outcomes benefit. When these challenges are addressed, it is anticipated that pulmonary functional imaging will have an expanding role in the evaluation and management of patients with lung disease. © RSNA, 2021 .

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33847518      PMCID: PMC8165948          DOI: 10.1148/radiol.2021204033

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   29.146


  95 in total

1.  Development of a pulmonary imaging biomarker pipeline for phenotyping of chronic lung disease.

Authors:  Fumin Guo; Dante Capaldi; Miranda Kirby; Khadija Sheikh; Sarah Svenningsen; David G McCormack; Aaron Fenster; Grace Parraga
Journal:  J Med Imaging (Bellingham)       Date:  2018-06-28

Review 2.  Imaging in Chronic Thromboembolic Pulmonary Hypertension.

Authors:  Rahul D Renapurkar; Sankaran Shrikanthan; Gustavo A Heresi; Charles T Lau; Deepa Gopalan
Journal:  J Thorac Imaging       Date:  2017-03       Impact factor: 3.000

3.  Exercise-induced bronchoconstriction: reproducibility of hyperpolarized 3He MR imaging.

Authors:  David J Niles; Stanley J Kruger; Bernard J Dardzinski; Amy Harman; Nizar N Jarjour; Marcella Ruddy; Scott K Nagle; Christopher J François; Sean B Fain
Journal:  Radiology       Date:  2012-11-20       Impact factor: 11.105

4.  Prognostic Value of Dual-Time-Point 18F-FDG PET for Idiopathic Pulmonary Fibrosis.

Authors:  Yukihiro Umeda; Yoshiki Demura; Miwa Morikawa; Masaki Anzai; Maiko Kadowaki; Shingo Ameshima; Tatsuro Tsuchida; Tetsuya Tsujikawa; Yasushi Kiyono; Hidehiko Okazawa; Takeshi Ishizaki; Tamotsu Ishizuka
Journal:  J Nucl Med       Date:  2015-09-10       Impact factor: 10.057

5.  Is ventilation heterogeneity related to asthma control?

Authors:  Sarah Svenningsen; Parameswaran Nair; Fumin Guo; David G McCormack; Grace Parraga
Journal:  Eur Respir J       Date:  2016-05-12       Impact factor: 16.671

6.  Evaluation of asthma with hyperpolarized helium-3 MRI: correlation with clinical severity and spirometry.

Authors:  Eduard E de Lange; Talissa A Altes; James T Patrie; John D Gaare; Jeffrey J Knake; John P Mugler; Thomas A Platts-Mills
Journal:  Chest       Date:  2006-10       Impact factor: 9.410

7.  Pulmonary Imaging Phenotypes of Chronic Obstructive Pulmonary Disease Using Multiparametric Response Maps.

Authors:  Jonathan L MacNeil; Dante P I Capaldi; Andrew R Westcott; Rachel L Eddy; Andrea L Barker; David G McCormack; Miranda Kirby; Grace Parraga
Journal:  Radiology       Date:  2020-02-25       Impact factor: 11.105

Review 8.  Functional imaging of the lungs with gas agents.

Authors:  Stanley J Kruger; Scott K Nagle; Marcus J Couch; Yoshiharu Ohno; Mitchell Albert; Sean B Fain
Journal:  J Magn Reson Imaging       Date:  2015-07-27       Impact factor: 4.813

Review 9.  COPD biomarkers and phenotypes: opportunities for better outcomes with precision imaging.

Authors:  George R Washko; Grace Parraga
Journal:  Eur Respir J       Date:  2018-11-29       Impact factor: 16.671

10.  EXPRESS: Statement on imaging and pulmonary hypertension from the Pulmonary Vascular Research Institute (PVRI).

Authors:  David G Kiely; David Levin; Paul Hassoun; David D Ivy; Pei-Ni Jone; Jumaa Bwika; Steven M Kawut; Jim Lordan; Angela Lungu; Jeremy Mazurek; Shahin Moledina; Horst Olschewski; Andrew Peacock; Goverdhan Dutt Puri; Farbod Rahaghi; Michal Schafer; Mark Schiebler; Nicholas Screaton; Merryn Tawhai; Edwin Jr Van Beek; Anton Vonk-Noordegraaf; Rebecca R Vanderpool; John Wort; Lan Zhao; Jim Wild; Jens Vogel-Claussen; Andrew J Swift
Journal:  Pulm Circ       Date:  2019-03-18       Impact factor: 3.017

View more
  2 in total

1.  Quantitative assessment of ventilation-perfusion relationships with gallium-68 positron emission tomography/computed tomography imaging in lung cancer patients.

Authors:  Zhuorui Li; Pierre-Yves Le Roux; Jason Callahan; Nicholas Hardcastle; Michael S Hofman; Shankar Siva; Tokihiro Yamamoto
Journal:  Phys Imaging Radiat Oncol       Date:  2022-04-11

2.  Statistical evaluation of the effectiveness of dual amplitude-gated stereotactic body radiotherapy using fiducial markers and lung volume.

Authors:  Yoshinori Tanabe; Hidekazu Tanaka
Journal:  Phys Imaging Radiat Oncol       Date:  2022-10-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.